COVID-19: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
m (Text replacement - "= A C " to "= AC ")
m (Text replacement - "u| first" to "u | first")
 
(46 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''COVID-19''', commonly referred to as '''COVID''' or even '''corona''', is '''Coronavirus Disease 19''', an infectious respiratory illness caused by the novel (new) [[severe acute respiratory syndrome coronavirus 2]] (SARS-CoV-2), a virus discovered in 2019.<ref name="WHO-QA">{{Cite web | url = https://www.who.int/news-room/q-a-detail/q-a-coronaviruses | title = Q&A on coronaviruses (COVID-19) | last = World Health Organization | first = | authorlink = World Health Organization | date = |website=[[World Health Organization]]|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-16}}</ref><ref name="CDC-coronoviruses">{{Cite web | url = https://www.cdc.gov/coronavirus/types.html | title = Human Coronavirus Types | last = Centers for Disease Control and Prevention | first = | authorlink = Centers for Disease Control and Prevention | date = 2020-02-27 | website = [[Centers for Disease Control and Prevention]]|language=en-us|archive-url=|archive-date=|url-status= | access-date = 2020-03-16}}</ref><ref>{{Cite journal | last = Li | first = Guangdi | authorlink = | last2 = Clercq| first2 = Erik De | authorlink2 = | date = Mar 2020 | title = Therapeutic options for the 2019 novel coronavirus (2019-nCoV) | url = https://www.nature.com/articles/d41573-020-00016-0|journal=Nature Reviews Drug Discovery|language=en|volume=19|issue=3 | pages = 149–150|doi=10.1038/d41573-020-00016-0|pmc=|pmid=|access-date=|quote=|via=}}</ref><ref>{{Cite web | url = https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it | title = Naming the coronavirus disease (COVID-19) and the virus that causes it|website=[[World Health Organization]]|language=en | access-date = 2020-03-28}}</ref>   
'''COVID-19''', commonly referred to as '''COVID''' or even '''corona''', is '''Coronavirus Disease 19''', an infectious respiratory illness caused by the novel (new) [[severe acute respiratory syndrome coronavirus 2]] (SARS-CoV-2), a virus discovered in 2019.<ref name="WHO-QA">{{Cite web | url = https://www.who.int/news-room/q-a-detail/q-a-coronaviruses | title = Q&A on coronaviruses (COVID-19) | last = World Health Organization | first = | author-link = World Health Organization | date = | website = [[World Health Organization]]|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-16}}</ref><ref name="CDC-coronoviruses">{{Cite web | url = https://www.cdc.gov/coronavirus/types.html | title = Human Coronavirus Types | last = Centers for Disease Control and Prevention | first = | author-link = Centers for Disease Control and Prevention | date = 2020-02-27 | website = [[Centers for Disease Control and Prevention]]|language=en-us|archive-url=|archive-date=|url-status= | access-date = 2020-03-16}}</ref><ref>{{Cite journal | last = Li | first = Guangdi | author-link = | last2 = Clercq | first2 = Erik De | author-link2 = | date = Mar 2020 | title = Therapeutic options for the 2019 novel coronavirus (2019-nCoV) | url = https://www.nature.com/articles/d41573-020-00016-0 | journal = Nature Reviews Drug Discovery|language=en | volume = 19 | issue = 3 | pages = 149–150|doi=10.1038/d41573-020-00016-0|pmc=|pmid=|access-date=|quote=|via=}}</ref><ref>{{Cite web | url = https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it | title = Naming the coronavirus disease (COVID-19) and the virus that causes it | website = [[World Health Organization]]|language=en | access-date = 2020-03-28}}</ref>   
[[File:Covid-19-lung-lesions.jpg|thumb|left|alt=Computer-aided identification of lesions on the lungs of COVID-19 patients.|'''COVID-19 can cause lesions on lungs, and pneumonia.'''<br>Author: [https://www.sciencedirect.com/science/article/pii/S2095177920302264 Shen et al. 2020. Journal of Pharmaceutical Analysis]. Copyright: CC-BY-NC-ND-4.0]]{{clear}}
[[File:Covid-19-lung-lesions.jpg|thumb|left|alt=Computer-aided identification of lesions on the lungs of COVID-19 patients.|'''COVID-19 can cause lesions on lungs, and pneumonia.'''<br>Author: [https://www.sciencedirect.com/science/article/pii/S2095177920302264 Shen et al. 2020. Journal of Pharmaceutical Analysis]. Copyright: CC-BY-NC-ND-4.0]]{{clear}}
COVID-19 was first identified in Wuhan, China, in December 2019,<ref name="WHO-QA" /> and can infect babies, children, and adults of any age.<ref>{{Cite journal | last = Wei | first = Min | last2 = Yuan | first2 = Jingping | last3 = Liu| first3 = Yu | last4 = Fu| first4 = Tao | last5 = Yu| first5 = Xue | last6 = Zhang | first6 = Zhi-Jiang | date = 2020-02-14 | title = Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China | url = https://jamanetwork.com/journals/jama/fullarticle/2761659|journal=JAMA|language=en|doi=10.1001/jama.2020.2131}}</ref> It spread globally, resulting in the 2019-2020 coronavirus pandemic.<ref>{{Cite journal | last = Hui | first = David S. | last2 = Azhar | first2 = Esam I. | last3 = Madani | first3 = Tariq A. | last4 = Ntoumi | first4 = Francine | last5 = Kock | first5 = Richard | last6 = Dar | first6 = Osman | last7 = Ippolito | first7 = Giuseppe | last8 = Mchugh | first8 = Timothy D. | last9 = Memish | first9 = Ziad A. | date = 2020-02-01 | title = The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China | url = https://www.ijidonline.com/article/S1201-9712(20)30011-4/abstract|journal=International Journal of Infectious Diseases|language=English|volume=91 | pages = 264–266|doi=10.1016/j.ijid.2020.01.009|issn=1201-9712|pmid=31953166}}</ref><ref>{{Cite web | url = https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 | title = WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020 | website = [[World Health Organization]]|language=en | access-date = 2020-03-28}}</ref> There is some evidence that COVID-19 may be a disease of the blood vessels, as well as a respiratory disease.<ref name="Ackermann2020">{{Cite journal | last = Ackermann | first = Maximilian | last2 = Verleden | first2 = Stijn E. | last3 = Kuehnel | first3 = Mark | last4 = Haverich | first4 = Axel | last5 = Welte | first5 = Tobias | last6 = Laenger | first6 = Florian | last7 = Vanstapel | first7 = Arno | last8 = Werlein | first8 = Christopher | last9 = Stark | first9 = Helge | date = 2020-07-09 | title = Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 | url = https://doi.org/10.1056/NEJMoa2015432|journal=New England Journal of Medicine|volume=383|issue=2 | pages = 120–128|doi=10.1056/NEJMoa2015432|issn=0028-4793|pmc =  7412750|pmid=32437596}}</ref><ref name="NPR-5Nov2020">{{Cite web | url = https://www.npr.org/sections/health-shots/2020/11/05/917317541/clots-strokes-and-rashes-is-covid-19-a-disease-of-the-blood-vessels | title = Clots, Strokes And Rashes. Is COVID-19 A Disease Of The Blood Vessels?|website=NPR.org|language=en | access-date = 2020-11-06}}</ref>
COVID-19 was first identified in Wuhan, China, in December 2019,<ref name="WHO-QA" /> and can infect babies, children, and adults of any age.<ref>{{Cite journal | last = Wei | first = Min | last2 = Yuan | first2 = Jingping | last3 = Liu | first3 = Yu | last4 = Fu | first4 = Tao | last5 = Yu | first5 = Xue | last6 = Zhang | first6 = Zhi-Jiang | date = 2020-02-14 | title = Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China | url = https://jamanetwork.com/journals/jama/fullarticle/2761659 | journal = JAMA|language=en|doi=10.1001/jama.2020.2131}}</ref> It spread globally, resulting in the 2019-2020 coronavirus pandemic.<ref>{{Cite journal | last = Hui | first = David S. | last2 = Azhar | first2 = Esam I. | last3 = Madani | first3 = Tariq A. | last4 = Ntoumi | first4 = Francine | last5 = Kock | first5 = Richard | last6 = Dar | first6 = Osman | last7 = Ippolito | first7 = Giuseppe | last8 = Mchugh | first8 = Timothy D. | last9 = Memish | first9 = Ziad A. | date = 2020-02-01 | title = The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China | url = https://www.ijidonline.com/article/S1201-9712(20)30011-4/abstract | journal = International Journal of Infectious Diseases|language=English | volume = 91 | pages = 264–266|doi=10.1016/j.ijid.2020.01.009|issn=1201-9712|pmid=31953166}}</ref><ref>{{Cite web | url = https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 | title = WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020 | website = [[World Health Organization]]|language=en | access-date = 2020-03-28}}</ref> There is some evidence that COVID-19 may be a disease of the blood vessels, as well as a respiratory disease.<ref name="Ackermann2020">{{Cite journal | last = Ackermann | first = Maximilian | last2 = Verleden | first2 = Stijn E. | last3 = Kuehnel | first3 = Mark | last4 = Haverich | first4 = Axel | last5 = Welte | first5 = Tobias | last6 = Laenger | first6 = Florian | last7 = Vanstapel | first7 = Arno | last8 = Werlein | first8 = Christopher | last9 = Stark | first9 = Helge | date = 2020-07-09 | title = Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 | url = https://doi.org/10.1056/NEJMoa2015432 | journal = New England Journal of Medicine | volume = 383 | issue = 2 | pages = 120–128|doi=10.1056/NEJMoa2015432|issn=0028-4793|pmc =  7412750|pmid=32437596}}</ref><ref name="NPR-5Nov2020">{{Cite web | url = https://www.npr.org/sections/health-shots/2020/11/05/917317541/clots-strokes-and-rashes-is-covid-19-a-disease-of-the-blood-vessels | title = Clots, Strokes And Rashes. Is COVID-19 A Disease Of The Blood Vessels? | website = NPR.org|language=en | access-date = 2020-11-06}}</ref>


== Symptoms ==
== Symptoms ==
Symptoms are usually mild and begin gradually, although around 1 in 6 people with COVID-19 need medical help.<ref name="WHO-QA" /> Some people become infected but don't develop any symptoms and don't feel unwell.<ref name="WHO-qa">{{Cite web | last = World Health Organization | first = | authorlink = World Health Organization | url =https://www.who.int/news-room/q-a-detail/q-a-coronaviruses | title = Q&A on coronaviruses (COVID-19)|website=[[World Health Organization]]|language=en | access-date = 2020-04-21}}</ref> These symptoms may appear 1-14 days after exposure; most commonly around five days.<ref name="WHO-qa" /><ref name="CDC-symptoms">{{Cite web | url = https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html | title = Coronavirus Disease 2019 (COVID-19) – Symptoms | last = CDC | date = 2020-03-20 | authorlink = Centers for Disease Control|website=Centers for Disease Control and Prevention|language=en-us | access-date = 2020-03-24}}</ref>
Symptoms are usually mild and begin gradually, although around 1 in 6 people with COVID-19 need medical help.<ref name="WHO-QA" /> Some people become infected but don't develop any symptoms and don't feel unwell.<ref name="WHO-qa">{{Cite web | last = World Health Organization | first = | author-link = World Health Organization | url =https://www.who.int/news-room/q-a-detail/q-a-coronaviruses | title = Q&A on coronaviruses (COVID-19) | website = [[World Health Organization]]|language=en | access-date = 2020-04-21}}</ref> These symptoms may appear 1-14 days after exposure; most commonly around five days.<ref name="WHO-qa" /><ref name="CDC-symptoms">{{Cite web | url = https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html | title = Coronavirus Disease 2019 (COVID-19) – Symptoms | last = CDC | date = 2020-03-20 | author-link = Centers for Disease Control | website = Centers for Disease Control and Prevention|language=en-us | access-date = 2020-03-24}}</ref>


== Mild COVID-19 ==
== Mild COVID-19 ==
The phrases '''''mild symptoms''''' and '''''mild or moderate cases''''' have commonly been used to decribe any patients not in need of urgent hospitalisation during the pandemic,<ref>{{Cite news |url =https://www.washingtonpost.com/opinions/i-probably-have-a-mild-to-moderate-case-of-covid-19-i-dont-think-i-could-survive-worse/2020/03/24/740b4d10-6de2-11ea-a3ec-70d7479d83f0_story.html | title = Opinion: I probably have a ‘mild to moderate’ case of covid-19. I don’t think I could survive worse. | last = von Drehle | first = David | date = Mar 24, 2020|work=Washington Post | access-date = 2020-10-12| archive-url = | archive-date = |url-status = | language=en-US|issn=0190-8286|quote=}}</ref><ref>{{Cite web | url = https://blogs.bmj.com/bmj/2020/07/28/nisreen-a-alwan-what-exactly-is-mild-covid-19/ | title = What exactly is mild covid-19? | last = Alwan | first = Nisreen A | authorlink = Nisreen Alwan | date = 2020-07-28 | website = The BMJ|language=en-US|archive-url=|archive-date=|url-status= | access-date = 2020-10-12}}</ref> yet considerable numbers of patients with COVID-19 who were considered mild or moderate cases were extremely ill or developed [[Long COVID|long-term symptoms]] which prevented any return to work or normal life.<ref name="Navabi2020">{{Cite journal | title = Long covid: How to define it and how to manage it | last = Nabavi | first = Nikki | url = https://www.bmj.com/content/370/bmj.m3489 | date = Sep 7, 2020|journal=BMJ|volume=370 | pages = bmj.m3489}}</ref><ref name="long-haulers-redefining">{{Cite news |url =https://www.theatlantic.com/health/archive/2020/08/long-haulers-covid-19-recognition-support-groups-symptoms/615382/ | title = Long-Haulers Are Redefining COVID-19 | last = Yong | first = Ed | date = Aug 19, 2020|work=The Atlantic | access-date = 2020-08-21| archive-url = | archive-date = |url-status = | issn=1072-7825|quote=}}</ref><ref name="BBClongcovid6m">https://www.bbc.co.uk/news/uk-england-leicestershire-54106073</ref>
The phrases '''''mild symptoms''''' and '''''mild or moderate cases''''' have commonly been used to decribe any patients not in need of urgent hospitalisation during the pandemic,<ref>{{Cite news |url =https://www.washingtonpost.com/opinions/i-probably-have-a-mild-to-moderate-case-of-covid-19-i-dont-think-i-could-survive-worse/2020/03/24/740b4d10-6de2-11ea-a3ec-70d7479d83f0_story.html | title = Opinion: I probably have a ‘mild to moderate’ case of covid-19. I don’t think I could survive worse. | last = von Drehle | first = David | date = Mar 24, 2020|work=Washington Post | access-date = 2020-10-12| archive-url = | archive-date = |url-status = | language=en-US|issn=0190-8286|quote=}}</ref><ref>{{Cite web | url = https://blogs.bmj.com/bmj/2020/07/28/nisreen-a-alwan-what-exactly-is-mild-covid-19/ | title = What exactly is mild covid-19? | last = Alwan | first = Nisreen A | author-link = Nisreen Alwan | date = 2020-07-28 | website = The BMJ|language=en-US|archive-url=|archive-date=|url-status= | access-date = 2020-10-12}}</ref> yet considerable numbers of patients with COVID-19 who were considered mild or moderate cases were extremely ill or developed [[Long COVID|long-term symptoms]] which prevented any return to work or normal life.<ref name="Navabi2020">{{Cite journal | title = Long covid: How to define it and how to manage it | last = Nabavi | first = Nikki | url = https://www.bmj.com/content/370/bmj.m3489 | date = Sep 7, 2020 | journal = BMJ | volume = 370 | pages = bmj.m3489}}</ref><ref name="long-haulers-redefining">{{Cite news |url =https://www.theatlantic.com/health/archive/2020/08/long-haulers-covid-19-recognition-support-groups-symptoms/615382/ | title = Long-Haulers Are Redefining COVID-19 | last = Yong | first = Ed | date = Aug 19, 2020|work=The Atlantic | access-date = 2020-08-21| archive-url = | archive-date = |url-status = | issn=1072-7825|quote=}}</ref><ref name="BBClongcovid6m">https://www.bbc.co.uk/news/uk-england-leicestershire-54106073</ref>


{{See also|Long COVID|Long COVID|Post-COVID-19 illness|Post-COVID illness||}}
{{See also|Long COVID|Long COVID|Post-COVID-19 illness|Post-COVID illness||}}
Line 14: Line 14:
* [[fever]]
* [[fever]]
* [[Fatigue|tiredness]]
* [[Fatigue|tiredness]]
* a new and continuous cough, coughing episodes, or a dry [[cough]]<ref>{{Cite web | url = https://www.nhs.uk/conditions/coronavirus-covid-19/symptoms-and-what-to-do/ | title = Symptoms and what to do - Coronavirus (COVID-19) | last = National Health Service | first = | authorlink = National Health Service | date = 2020-03-24 | website = nhs.uk|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-04-21}}</ref><ref name="WHO-qa" /><ref name="CDC-symptoms" />
* a new and continuous cough, coughing episodes, or a dry [[cough]]<ref>{{Cite web | url = https://www.nhs.uk/conditions/coronavirus-covid-19/symptoms-and-what-to-do/ | title = Symptoms and what to do - Coronavirus (COVID-19) | last = National Health Service | first = | author-link = National Health Service | date = 2020-03-24 | website = nhs.uk|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-04-21}}</ref><ref name="WHO-qa" /><ref name="CDC-symptoms" />
Most patients only have one or two of the common symptoms.<ref name="WHO-qa" /><ref name="Mizumoto">{{Cite journal | last = Mizumoto | first = Kenji | last2 = Kagaya | first2 = Katsushi | last3 = Zarebski | first3 = Alexander | last4 = Chowell | first4 = Gerardo | date = 2020-03-12 | title = Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 | url = https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.10.2000180|journal=Eurosurveillance|language=en|volume=25|issue=10 | pages = 2000180|doi=10.2807/1560-7917.ES.2020.25.10.2000180|issn=1560-7917|pmc =  7078829|pmid=32183930}}</ref><ref name="Lan2020" /><ref name="WHO-symptoms">{{Cite web |url= https://www.who.int/westernpacific/health-topics/coronavirus | title = Coronavirus | last = World Health Organization | date = 2020-04-16 | authorlink = World Health Organization|website=World Health Organization|language=en-us | access-date = 2020-04-21}}</ref>
Most patients only have one or two of the common symptoms.<ref name="WHO-qa" /><ref name="Mizumoto">{{Cite journal | last = Mizumoto | first = Kenji | last2 = Kagaya | first2 = Katsushi | last3 = Zarebski | first3 = Alexander | last4 = Chowell | first4 = Gerardo | date = 2020-03-12 | title = Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 | url = https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.10.2000180 | journal = Eurosurveillance|language=en | volume = 25 | issue = 10 | pages = 2000180|doi=10.2807/1560-7917.ES.2020.25.10.2000180|issn=1560-7917|pmc =  7078829|pmid=32183930}}</ref><ref name="Lan2020" /><ref name="WHO-symptoms">{{Cite web |url= https://www.who.int/westernpacific/health-topics/coronavirus | title = Coronavirus | last = World Health Organization | date = 2020-04-16 | author-link = World Health Organization | website = World Health Organization|language=en-us | access-date = 2020-04-21}}</ref>


=== Other Symptoms ===
=== Other Symptoms ===
Line 35: Line 35:


===Neurological symptoms===
===Neurological symptoms===
Mao et al. (2020) reported that 36% of a group of 214 COVID-19 patients admitted to hospitals in Wuhan, China, had "neurologic manifestations" of the disease.<ref name="Mao2020">{{Cite journal | last = Mao | first = Ling | last2 = Jin | first2 = Huijuan | last3 = Wang | first3 = Mengdie | last4 = Hu| first4 = Yu | last5 = Chen | first5 = Shengcai | last6 = He | first6 = Quanwei | last7 = Chang | first7 = Jiang | last8 = Hong | first8 = Candong | last9 = Zhou| first9 = Yifan | date = 2020-06-01 | title = Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China | url = https://jamanetwork.com/journals/jamaneurology/fullarticle/2764549|journal=JAMA Neurology|language=en|volume=77|issue=6 | pages = 683|doi=10.1001/jamaneurol.2020.1127|issn=2168-6149}}</ref>
Mao et al. (2020) reported that 36% of a group of 214 COVID-19 patients admitted to hospitals in Wuhan, China, had "neurologic manifestations" of the disease.<ref name="Mao2020">{{Cite journal | last = Mao | first = Ling | last2 = Jin | first2 = Huijuan | last3 = Wang | first3 = Mengdie | last4 = Hu | first4 = Yu | last5 = Chen | first5 = Shengcai | last6 = He | first6 = Quanwei | last7 = Chang | first7 = Jiang | last8 = Hong | first8 = Candong | last9 = Zhou | first9 = Yifan | date = 2020-06-01 | title = Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China | url = https://jamanetwork.com/journals/jamaneurology/fullarticle/2764549 | journal = JAMA Neurology|language=en | volume = 77 | issue = 6 | pages = 683|doi=10.1001/jamaneurol.2020.1127|issn=2168-6149}}</ref>


Neurological symptoms were:
Neurological symptoms were:
Line 60: Line 60:
==<span id="asymptomaticcarriers">Asymptomatic carriers</span>==
==<span id="asymptomaticcarriers">Asymptomatic carriers</span>==
[[File:Covid-19-virus.png|thumb|upright=0.4|'''The SARS-CoV-2 virus causes COVID-19.'''<br>Author: CDC]]
[[File:Covid-19-virus.png|thumb|upright=0.4|'''The SARS-CoV-2 virus causes COVID-19.'''<br>Author: CDC]]
A number of studies have found that some people who test positive for COVID-19 do not have any symptoms of illness or a raised temperature, and have normal blood test results, but are able to infect others, some of whom developed severe COVID-19 [[pneumonia]] as a result of COVID-19.<ref name="Bai2020">{{Cite journal | last = Bai | first = Yan | last2 = Yao | first2 = Lingsheng | last3 = Wei | first3 = Tao | last4 = Tian | first4 = Fei | last5 = Jin | first5 = Dong-Yan | last6 = Chen | first6 = Lijuan | last7 = Wang | first7 = Meiyun | date = 2020-02-21 | title = Presumed Asymptomatic Carrier Transmission of COVID-19 | url = https://jamanetwork.com/journals/jama/fullarticle/2762028|journal=JAMA|language=en|doi=10.1001/jama.2020.2565}}</ref><ref name="Chan2019">{{Cite journal | last = Chan | first = Jasper Fuk-Woo | last2 = Yuan | first2 = Shuofeng | last3 = Kok | first3 = Kin-Hang | last4 = To | first4 = Kelvin Kai-Wang | last5 = Chu| first5 = Hin | last6 = Yang | first6 = Jin | last7 = Xing | first7 = Fanfan | last8 = Liu| first8 = Jieling | last9 = Yip | first9 = Cyril Chik-Yan | date = 2020-02-15 | title = A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster |url =https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30154-9/abstract|journal=The Lancet|language=English|volume=395|issue=10223 | pages = 514–523|doi=10.1016/S0140-6736(20)30154-9|issn=0140-6736|pmid=31986261}}</ref><ref name="delRio2020">{{Cite journal | last = del Rio | first = Carlos | authorlink = | last2 = Malani | first2 = Preeti N. | authorlink2 = | date = 2020-02-28 | title = COVID-19—New Insights on a Rapidly Changing Epidemic | url = https://jamanetwork.com/journals/jama/fullarticle/2762510|journal=JAMA|language=en|volume=|issue= | pages = |doi=10.1001/jama.2020.3072|pmc=|pmid=|access-date=|quote=|via=}}</ref> Some asymptomatic carriers have abnormal chest CT scans, and some do not. False negative tests have also been reported.<ref name="Bai2020" /><ref name="Chan2019" />
A number of studies have found that some people who test positive for COVID-19 do not have any symptoms of illness or a raised temperature, and have normal blood test results, but are able to infect others, some of whom developed severe COVID-19 [[pneumonia]] as a result of COVID-19.<ref name="Bai2020">{{Cite journal | last = Bai | first = Yan | last2 = Yao | first2 = Lingsheng | last3 = Wei | first3 = Tao | last4 = Tian | first4 = Fei | last5 = Jin | first5 = Dong-Yan | last6 = Chen | first6 = Lijuan | last7 = Wang | first7 = Meiyun | date = 2020-02-21 | title = Presumed Asymptomatic Carrier Transmission of COVID-19 | url = https://jamanetwork.com/journals/jama/fullarticle/2762028 | journal = JAMA|language=en|doi=10.1001/jama.2020.2565}}</ref><ref name="Chan2019">{{Cite journal | last = Chan | first = Jasper Fuk-Woo | last2 = Yuan | first2 = Shuofeng | last3 = Kok | first3 = Kin-Hang | last4 = To | first4 = Kelvin Kai-Wang | last5 = Chu | first5 = Hin | last6 = Yang | first6 = Jin | last7 = Xing | first7 = Fanfan | last8 = Liu | first8 = Jieling | last9 = Yip | first9 = Cyril Chik-Yan | date = 2020-02-15 | title = A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster |url =https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30154-9/abstract | journal = The Lancet|language=English | volume = 395 | issue = 10223 | pages = 514–523|doi=10.1016/S0140-6736(20)30154-9|issn=0140-6736|pmid=31986261}}</ref><ref name="delRio2020">{{Cite journal | last = del Rio | first = Carlos | author-link = | last2 = Malani | first2 = Preeti N. | author-link2 = | date = 2020-02-28 | title = COVID-19—New Insights on a Rapidly Changing Epidemic | url = https://jamanetwork.com/journals/jama/fullarticle/2762510 | journal = JAMA|language=en | volume = | issue = | pages = |doi=10.1001/jama.2020.3072|pmc=|pmid=|access-date=|quote=|via=}}</ref> Some asymptomatic carriers have abnormal chest CT scans, and some do not. False negative tests have also been reported.<ref name="Bai2020" /><ref name="Chan2019" />


Estimates of the number of asymptomatic carriers vary wildly. Mizumoto et al. (2020) estimated that asymptomatic carriers accounted for 17.9% of the COVID-19 positive people on the ''Diamond Princess'' cruise ship, which was quarantined for 14 day after a previous passenger  developed the illness.<ref name="Mizumoto" />
Estimates of the number of asymptomatic carriers vary wildly. Mizumoto et al. (2020) estimated that asymptomatic carriers accounted for 17.9% of the COVID-19 positive people on the ''Diamond Princess'' cruise ship, which was quarantined for 14 day after a previous passenger  developed the illness.<ref name="Mizumoto" />


==<span id="recovered">Recovered patients testing positive</span>==
==<span id="recovered">Recovered patients testing positive</span>==
Lan et al (2020) identified a group of 4 recovered patients who continued to test positive for COVID-19 after recovery; suggesting that they may still be infectious.<ref name="Lan2020">{{Cite journal | last = Lan | first = Lan | last2 = Xu| first2 = Dan | last3 = Ye | first3 = Guangming | last4 = Xia | first4 = Chen | last5 = Wang | first5 = Shaokang | last6 = Li | first6 = Yirong | last7 = Xu| first7 = Haibo | date = 2020-02-27 | title = Positive RT-PCR Test Results in Patients Recovered From COVID-19 | url = https://jamanetwork.com/journals/jama/fullarticle/2762452|journal=JAMA|language=en|doi=10.1001/jama.2020.2783}}</ref> It is not known whether patients who have recovered may be reinfected later, or whether those who later needed treatment actually relapsed, or if recovered patients who later test positive do so because of issues with the diagnostic test's accuracy.<ref>{{Cite web | url = https://www.snopes.com/fact-check/covid-19-reinfection/ | title = Can People Who Recover from COVID-19 Become Reinfected?|website=Snopes.com|language=en-US | access-date = 2020-03-26}}</ref> Another study found group of 5 recovered patients were found to have reactivated COVID-19.<ref>{{Cite journal | last = Ye | first = Guangming | last2 = Pan | first2 = Zhenyu | last3 = Pan | first3 = Yunbao | last4 = Deng | first4 = Qiaoling | last5 = Chen | first5 = Liangjun | last6 = Li | first6 = Jin | last7 = Li | first7 = Yirong | last8 = Wang | first8 = Xinghuan | date = 2020-03-11 | title = Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation | url =https://www.journalofinfection.com/article/S0163-4453(20)30114-6/abstract|journal=Journal of Infection|language=English|volume=0|issue=0|doi=10.1016/j.jinf.2020.03.001|issn=0163-4453|pmid=32171867}}</ref>
Lan et al (2020) identified a group of 4 recovered patients who continued to test positive for COVID-19 after recovery; suggesting that they may still be infectious.<ref name="Lan2020">{{Cite journal | last = Lan | first = Lan | last2 = Xu | first2 = Dan | last3 = Ye | first3 = Guangming | last4 = Xia | first4 = Chen | last5 = Wang | first5 = Shaokang | last6 = Li | first6 = Yirong | last7 = Xu | first7 = Haibo | date = 2020-02-27 | title = Positive RT-PCR Test Results in Patients Recovered From COVID-19 | url = https://jamanetwork.com/journals/jama/fullarticle/2762452 | journal = JAMA|language=en|doi=10.1001/jama.2020.2783}}</ref> It is not known whether patients who have recovered may be reinfected later, or whether those who later needed treatment actually relapsed, or if recovered patients who later test positive do so because of issues with the diagnostic test's accuracy.<ref>{{Cite web | url = https://www.snopes.com/fact-check/covid-19-reinfection/ | title = Can People Who Recover from COVID-19 Become Reinfected? | website = Snopes.com|language=en-US | access-date = 2020-03-26}}</ref> Another study found group of 5 recovered patients were found to have reactivated COVID-19.<ref>{{Cite journal | last = Ye | first = Guangming | last2 = Pan | first2 = Zhenyu | last3 = Pan | first3 = Yunbao | last4 = Deng | first4 = Qiaoling | last5 = Chen | first5 = Liangjun | last6 = Li | first6 = Jin | last7 = Li | first7 = Yirong | last8 = Wang | first8 = Xinghuan | date = 2020-03-11 | title = Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation | url =https://www.journalofinfection.com/article/S0163-4453(20)30114-6/abstract | journal = Journal of Infection|language=English | volume = 0 | issue = 0|doi=10.1016/j.jinf.2020.03.001|issn=0163-4453|pmid=32171867}}</ref>


==ME/CFS==
==ME/CFS==
Line 74: Line 74:


====<span id="catchingcovid19">Risk of COVID-19 in patients with ME/CFS</span>====
====<span id="catchingcovid19">Risk of COVID-19 in patients with ME/CFS</span>====
There is a lack of evidence about ME/CFS patients developing COVID-19 illness; but a number of medical advisors have given their expert opinions on this. Immunologist and [[Myalgic encephalomyelitis|ME]] researcher Dr [[Nancy Klimas]] has said she believes people with ME/CFS are at a little higher risk of developing COVID-19 after exposure to the virus;<ref name="Klimas20200313">{{Cite web | url = https://www.youtube.com/watch?v=pkGXiJ1jM14 | title = COVID-19 and ME/CFS - Dr Nancy Klimas, Mar 13, 2020 | last = Klimas | first = Nancy | date = 2020-03-13|work=|access-date=Mar 24, 2020| archive-url = | archive-date = |url-status = | quote= | authorlink = Nancy Klimas}}</ref> Dr [[Nigel Speight]], Dr [[William Weir]] and Dr [[Charles Shepherd]] have said they do not think there is an increased risk.<ref name="SpeightWeirMar20" /><ref name="SpeightMar20" /><ref name="MEA16Mar20" /> Dr [[Lucinda Bateman]] has said this is unknown.<ref name="Bateman20200323QA">{{Cite web | title = COVID-19 and ME/CFS/FM Frequently Asked Questions | last = Bateman | first = Lucinda | authorlink = Lucinda Bateman|website=Bateman-Horne Center | date = 2020-03-23 | url = http://www.batemanhornecenter.org/wp-content/uploads/2020/03/COVID-19-FAQ-Public.pdf}}</ref>Klimas, Speight, Weir, Shepherd and Bateman have all advised ME/CFS patients to take additional precautions, and highlighted that there is a risk of ME/CFS becoming significantly worse after viral infections or after COVID-19.<ref name="Klimas20200313" /><ref name="SpeightWeirMar20" /><ref name="SpeightMar20" /><ref name="MEA16Mar20" /><ref name="Bateman20200323QA" />
There is a lack of evidence about ME/CFS patients developing COVID-19 illness; but a number of medical advisors have given their expert opinions on this. Immunologist and [[Myalgic encephalomyelitis|ME]] researcher Dr [[Nancy Klimas]] has said she believes people with ME/CFS are at a little higher risk of developing COVID-19 after exposure to the virus;<ref name="Klimas20200313">{{Cite web | url = https://www.youtube.com/watch?v=pkGXiJ1jM14 | title = COVID-19 and ME/CFS - Dr Nancy Klimas, Mar 13, 2020 | last = Klimas | first = Nancy | date = 2020-03-13|work=|access-date=Mar 24, 2020| archive-url = | archive-date = |url-status = | quote= | author-link = Nancy Klimas}}</ref> Dr [[Nigel Speight]], Dr [[William Weir]] and Dr [[Charles Shepherd]] have said they do not think there is an increased risk.<ref name="SpeightWeirMar20" /><ref name="SpeightMar20" /><ref name="MEA16Mar20" /> Dr [[Lucinda Bateman]] has said this is unknown.<ref name="Bateman20200323QA">{{Cite web | title = COVID-19 and ME/CFS/FM Frequently Asked Questions | last = Bateman | first = Lucinda | author-link = Lucinda Bateman | website = Bateman-Horne Center | date = 2020-03-23 | url = http://www.batemanhornecenter.org/wp-content/uploads/2020/03/COVID-19-FAQ-Public.pdf}}</ref>Klimas, Speight, Weir, Shepherd and Bateman have all advised ME/CFS patients to take additional precautions, and highlighted that there is a risk of ME/CFS becoming significantly worse after viral infections or after COVID-19.<ref name="Klimas20200313" /><ref name="SpeightWeirMar20" /><ref name="SpeightMar20" /><ref name="MEA16Mar20" /><ref name="Bateman20200323QA" />
      
      
ME/CFS includes [[:Category:Immune signs and symptoms|immune symptoms]] including a [[sore throat]], [[swollen lymph nodes]], and [[flu-like symptoms]], but patients are generally '''''not''''' considered to be severely immunocompromised, and immunosuppressant medications are unlikely to be used by most ME/CFS patients. <ref name="Klimas20200313" /> <ref name="canadianconsensus">{{Citation | last1 = Carruthers | first1 = Bruce M. | authorlink1 = Bruce Carruthers | last2 = Jain | first2 = Anil Kumar | authorlink2 = Anil Kumar Jain | last3 = De Meirleir | first3 = Kenny L. | authorlink3 = Kenny De Meirleir | last4 = Peterson | first4 = Daniel L. | authorlink4 = Daniel Peterson | last5 = Klimas | first5 = Nancy G. | authorlink5 = Nancy Klimas | last6 = Lerner | first6 = A. Martin | authorlink6 = Martin Lerner | last7 = Bested | first7 = Alison C. | authorlink7 = Alison Bested | last8 = Flor-Henry | first8 = Pierre | authorlink8 = Pierre Flor-Henry | last9 =Joshi | first9 = Pradip | authorlink9 = Pradip Joshi | last10 = Powles | first10 = AC Peter | authorlink10 = AC Peter Powles | last11 = Sherkey | first11 = Jeffrey A.| authorlink11 = Jeffrey Sherkey | last12 = van de Sande | first12 = Marjorie I. | authorlink12 = Marjorie van de Sande | title = Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols | journal = Journal of Chronic Fatigue Syndrome | volume = 11 | issue = 2 | page = 7-115 | date = 2003 | pmid = | doi = 10.1300/J092v11n01_02 | url = http://www.investinme.org/Documents/PDFdocuments/CanadianDefinitionME-CFS.pdf }}</ref><ref name="ICP2011primer">{{citation | last1 = Carruthers | first1 = BM | authorlink1 = Bruce Carruthers | last2 = van de Sande | first2 = MI | authorlink2 = Marjorie van de Sande | last3 = De Meirleir | first3 = KL | authorlink3 = Kenny de Meirleir | last4 = Klimas | first4 = NG | authorlink4 = Nancy Klimas | last5 = Broderick | first5 = G | authorlink5 = Gordon Broderick | last6 = Mitchell | first6 = T | authorlink6 = Terry Mitchell | last7 = Staines | first7 = D | authorlink7 = Donald Staines | last8 = Powles | first8 = ACP | authorlink8 = AC Peter Powles | last9 = Speight | first9 = N | authorlink9 = Nigel Speight | last10 = Vallings | first10 = R | authorlink10 = Rosamund Vallings | last11 = Bateman | first11 =  L | authorlink11 = Lucinda Bateman | last12 = Bell | first12 = DS | authorlink12 = David Bell | last13 = Carlo-Stella | first13 =  N | authorlink13= Nicoletta Carlo-Stella | last14 = Chia | first14 =  J | authorlink14= John Chia | last15 = Darragh | first15 =  A | authorlink15= Austin Darragh | last16 = Gerken | first16 =  A | authorlink16= Anne Gerken | last17 = Jo | first17 =  D | authorlink17= Daehyun Jo | last18 = Lewis | first18 =  DP | authorlink18= Donald Lewis | last19 = Light | first19 = AR | authorlink19= Alan Light | last20 = Light | first20 =  KC | authorlink20= Kathleen Light | last21 = Marshall-Gradisnik | first21 =  S | authorlink21= Sonya Marshall-Gradisnik | last22 = McLaren-Howard | first22 =  J | authorlink22= John McLaren-Howard | last23 = Mena | first23 =  I | authorlink23= Ismael Mena | last24 = Miwa | first24 =  K | authorlink24= Kunihisa Miwa | last25 = Murovska | first25 =  M | authorlink25= Modra Murovska | last26 = Stevens | first26 =  SR | authorlink26= Staci Stevens | title = Myalgic encephalomyelitis: Adult & Paediatric: International Consensus Primer for Medical Practitioners | date = 2012
ME/CFS includes [[:Category:Immune signs and symptoms|immune symptoms]] including a [[sore throat]], [[swollen lymph nodes]], and [[flu-like symptoms]], but patients are generally '''''not''''' considered to be severely immunocompromised, and immunosuppressant medications are unlikely to be used by most ME/CFS patients. <ref name="Klimas20200313" /> <ref name="canadianconsensus">{{Citation | last1 = Carruthers | first1 = Bruce M. | author-link1 = Bruce Carruthers | last2 = Jain | first2 = Anil Kumar | author-link2 = Anil Kumar Jain | last3 = De Meirleir | first3 = Kenny L. | author-link3 = Kenny De Meirleir | last4 = Peterson | first4 = Daniel L. | author-link4 = Daniel Peterson | last5 = Klimas | first5 = Nancy G. | author-link5 = Nancy Klimas | last6 = Lerner | first6 = A. Martin | author-link6 = Martin Lerner | last7 = Bested | first7 = Alison C. | author-link8 = Alison Bested | last8 = Flor-Henry | first8 = Pierre | author-link8 = Pierre Flor-Henry | last9 =Joshi | first9 = Pradip | author-link9 = Pradip Joshi | last10 = Powles | first10 = AC Peter | author-link10 = A C Peter Powles | last11 = Sherkey | first11 = Jeffrey A. | author-link11 = Jeffrey Sherkey | last12 = van de Sande | first12 = Marjorie I. | author-link12 = Marjorie van de Sande | title = Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols | journal = Journal of Chronic Fatigue Syndrome | volume = 11 | issue = 2 | pages = 7-115 | date = 2003 | pmid = | doi = 10.1300/J092v11n01_02 | url = http://www.investinme.org/Documents/PDFdocuments/CanadianDefinitionME-CFS.pdf }}</ref><ref name="ICP2011primer">{{citation | last1 = Carruthers | first1 = BM | author-link1 = Bruce Carruthers | last2 = van de Sande | first2 = MI | author-link2 = Marjorie van de Sande | last3 = De Meirleir | first3 = KL | author-link3 = Kenny de Meirleir | last4 = Klimas | first4 = NG | author-link4 = Nancy Klimas | last5 = Broderick | first5 = G | author-link5 = Gordon Broderick | last6 = Mitchell | first6 = T | author-link6 = Terry Mitchell | last7 = Staines | first7 = D | author-link8 = Donald Staines | last8 = Powles | first8 = ACP | author-link8 = A C Peter Powles | last9 = Speight | first9 = N | author-link9 = Nigel Speight | last10 = Vallings | first10 = R | author-link10 = Rosamund Vallings | last11 = Bateman | first11 =  L | author-link11 = Lucinda Bateman | last12 = Bell | first12 = DS | author-link12 = David Bell | last13 = Carlo-Stella | first13 =  N | author-link13 = Nicoletta Carlo-Stella | last14 = Chia | first14 =  J | author-link14 = John Chia | last15 = Darragh | first15 =  A | author-link15 = Austin Darragh | last16 = Gerken | first16 =  A | author-link16 = Anne Gerken | last17 = Jo | first17 =  D | author-link17 = Daehyun Jo | last18 = Lewis | first18 =  DP | author-link18 = Donald Lewis | last19 = Light | first19 = AR | author-link19 = Alan Light | last20 = Light | first20 =  KC | author-link20 = Kathleen Light | last21 = Marshall-Gradisnik | first21 =  S | author-link21 = Sonya Marshall-Gradisnik | last22 = McLaren-Howard | first22 =  J | author-link22 = John McLaren-Howard | last23 = Mena | first23 =  I | author-link23 = Ismael Mena | last24 = Miwa | first24 =  K | author-link24 = Kunihisa Miwa | last25 = Murovska | first25 =  M | author-link25= Modra Murovska | last26 = Stevens | first26 =  SR | author-link26 = Staci Stevens | title = Myalgic encephalomyelitis: Adult & Paediatric: International Consensus Primer for Medical Practitioners | date = 2012
| isbn = 978-0-9739335-3-6 | url = http://www.investinme.org/Documents/Guidelines/Myalgic%20Encephalomyelitis%20International%20Consensus%20Primer%20-2012-11-26.pdf }}</ref> A study in 2013 assessed immune system responses to the flu [[vaccine]] in people with ME/CFS, and found them similar to the immune responses of healthy controls, which indicated that vaccine effectiveness was similar in ME/CFS patients, although the study did not include a long-term follow-up to assess duration of vaccine effectiveness or overall effect on ME/CFS symptoms.<ref>{{Cite journal | last = Prinsen | first = Hetty | authorlink = | last2 = de Vries | first2 = I. Jolanda M. | authorlink2 = | last3 = Torensma | first3 = Ruurd | authorlink3 = | last4 = Pots | first4 = Jeanette M. | authorlink4 = | last5 = Mulder | first5 = Sasja F. | authorlink5 = | last6 = van Herpen | first6 = Carla M. L. | authorlink6 = | last7 = Elving | first7 = Lammy D. | last8 = Bleijenberg | first8 = Gijs | authorlink8 = Gijs Bleijenberg | last9 = Stelma | first9 = Foekje F. | date = 2012-12-17 | title = Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome | url =https://doi.org/10.1186/1471-2172-13-71|journal=BMC Immunology|volume=13|issue=1 | pages = 71|doi=10.1186/1471-2172-13-71|issn=1471-2172|pmc =  3534525|pmid=23244635|access-date=|quote=|via=}}</ref> This means most ME/CFS patients would '''''not''''' be considered to be at very high risk of COVID-19 illness.<ref name="Klimas20200313" />
| isbn = 978-0-9739335-3-6 | url = http://www.investinme.org/Documents/Guidelines/Myalgic%20Encephalomyelitis%20International%20Consensus%20Primer%20-2012-11-26.pdf }}</ref> A study in 2013 assessed immune system responses to the flu [[vaccine]] in people with ME/CFS, and found them similar to the immune responses of healthy controls, which indicated that vaccine effectiveness was similar in ME/CFS patients, although the study did not include a long-term follow-up to assess duration of vaccine effectiveness or overall effect on ME/CFS symptoms.<ref>{{Cite journal | last = Prinsen | first = Hetty | author-link = | last2 = de Vries | first2 = I. Jolanda M. | author-link2 = | last3 = Torensma | first3 = Ruurd | author-link3 = | last4 = Pots | first4 = Jeanette M. | author-link4 = | last5 = Mulder | first5 = Sasja F. | author-link5 = | last6 = van Herpen | first6 = Carla M. L. | author-link6 = | last7 = Elving | first7 = Lammy D. | last8 = Bleijenberg | first8 = Gijs | author-link8 = Gijs Bleijenberg | last9 = Stelma | first9 = Foekje F. | date = 2012-12-17 | title = Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome | url =https://doi.org/10.1186/1471-2172-13-71 | journal = BMC Immunology | volume = 13 | issue = 1 | pages = 71|doi=10.1186/1471-2172-13-71|issn=1471-2172|pmc =  3534525|pmid=23244635|access-date=|quote=|via=}}</ref> This means most ME/CFS patients would '''''not''''' be considered to be at very high risk of COVID-19 illness.<ref name="Klimas20200313" />


The unproven [[autoimmune hypothesis]] states that a subtype of ME involves autoimmunity, which is an overactive immune system rather than a weakened immune response.<ref name="OMF2018research">{{Cite web | url = https://www.omf.ngo/2018/02/28/omf-funded-research-t-cells-molecular-immunology/ | title = OMF-funded research: T cells and molecular immunology | last = Open Medicine Foundation | first = | authorlink = Open Medicine Foundation | date = Feb 28, 2018 | website = Open Medicine Foundation|language=en-US|archive-url=|archive-date=|url-status= | access-date = 2019-07-11}}</ref> Evidence for this theory is limited.
The unproven [[autoimmune hypothesis]] states that a subtype of ME involves autoimmunity, which is an overactive immune system rather than a weakened immune response.<ref name="OMF2018research">{{Cite web | url = https://www.omf.ngo/2018/02/28/omf-funded-research-t-cells-molecular-immunology/ | title = OMF-funded research: T cells and molecular immunology | last = Open Medicine Foundation | first = | author-link = Open Medicine Foundation | date = Feb 28, 2018 | website = Open Medicine Foundation|language=en-US|archive-url=|archive-date=|url-status= | access-date = 2019-07-11}}</ref> Evidence for this theory is limited.


===Drug related risks===
===Drug related risks===
The following drugs may be used for some ME/CFS symptoms and are a possible concern
The following drugs may be used for some ME/CFS symptoms and are a possible concern
* '''<span id="ibuprofen">[[Ibuprofen]]</span>''' - Ibuprofen drugs (Nurofen, Bruprofen, Advil, Midol, Motrin, Motrin) are anti-inflammatories commonly used for cold/flu symptoms and for ME/CFS. There have been some reports that ibuprofen taken for COVID-19 may prolong the illness and increase it's severity. Several countries including the UK and France now recommend that people with suspected or confirmed COVID-19 avoid ibuprofen and '''use paracetamol / acetaminophen''' (e.g., Tylenol) instead, although the evidence for this is relatively limited.<ref name="MEA16Mar20" /><ref name="Day20200317">{{Cite journal | last = Day | first = Michael | date = 2020-03-17 | title = Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists |url =https://www.bmj.com/content/368/bmj.m1086|journal=BMJ|language=en|volume=368|doi=10.1136/bmj.m1086|issn=1756-1833|pmid=32184201}}</ref><ref>{{Cite web | url = https://www.nhs.uk/conditions/coronavirus-covid-19/self-isolation-advice/ | title = Stay at home advice - Coronavirus (COVID-19) | last = National Health Service | first = | authorlink = National Health Service | date = 2020-02-28 | website = nhs.uk|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-23}}</ref> There is no suggestion that ibuprofen affects the risk of catching COVID-19.
* '''<span id="ibuprofen">[[Ibuprofen]]</span>''' - Ibuprofen drugs (Nurofen, Bruprofen, Advil, Midol, Motrin, Motrin) are anti-inflammatories commonly used for cold/flu symptoms and for ME/CFS. There have been some reports that ibuprofen taken for COVID-19 may prolong the illness and increase it's severity. Several countries including the UK and France now recommend that people with suspected or confirmed COVID-19 avoid ibuprofen and '''use paracetamol / acetaminophen''' (e.g., Tylenol) instead, although the evidence for this is relatively limited.<ref name="MEA16Mar20" /><ref name="Day20200317">{{Cite journal | last = Day | first = Michael | date = 2020-03-17 | title = Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists |url =https://www.bmj.com/content/368/bmj.m1086 | journal = BMJ|language=en | volume = 368|doi=10.1136/bmj.m1086|issn=1756-1833|pmid=32184201}}</ref><ref>{{Cite web | url = https://www.nhs.uk/conditions/coronavirus-covid-19/self-isolation-advice/ | title = Stay at home advice - Coronavirus (COVID-19) | last = National Health Service | first = | author-link = National Health Service | date = 2020-02-28 | website = nhs.uk|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-23}}</ref> There is no suggestion that ibuprofen affects the risk of catching COVID-19.
* '''[[Rituximab]]''' - The MS Society has stated that taking rituximab, which has been used in clinical trials for ME/CFS, may affect the risk of catching COVID-19.<ref name="Covid-19-MS">{{Cite web | url = https://www.mssociety.org.uk/about-ms/treatments-and-therapies/disease-modifying-therapies/covid-19-coronavirus-and-ms | title = COVID-19 coronavirus and MS | last = MS Society | first = | authorlink = | date = | website = mssociety.org.uk|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-23}}</ref><ref>{{Cite web | url = https://renal.org/wp-content/uploads/2020/03/BAPN-COVID-19-patient-info-for-HD.PD_.Immunosuppression-17March20.pdf | title=Coronavirus (SARS-CoV-2) and its associated illness (COVID-19) {{!}} Information and Guidance for Children on Haemodialysis, Peritoneal Dialysis and Immune suppression (including Renal Transplants) | last = Renal Association | first = | authorlink = | date = 2020-03-17 | website = renal.org|archive-url=|archive-date=|url-status= | access-date = 2020-03-23}}</ref>
* '''[[Rituximab]]''' - The MS Society has stated that taking rituximab, which has been used in clinical trials for ME/CFS, may affect the risk of catching COVID-19.<ref name="Covid-19-MS">{{Cite web | url = https://www.mssociety.org.uk/about-ms/treatments-and-therapies/disease-modifying-therapies/covid-19-coronavirus-and-ms | title = COVID-19 coronavirus and MS | last = MS Society | first = | author-link = | date = | website = mssociety.org.uk|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-23}}</ref><ref>{{Cite web | url = https://renal.org/wp-content/uploads/2020/03/BAPN-COVID-19-patient-info-for-HD.PD_.Immunosuppression-17March20.pdf | title=Coronavirus (SARS-CoV-2) and its associated illness (COVID-19) {{!}} Information and Guidance for Children on Haemodialysis, Peritoneal Dialysis and Immune suppression (including Renal Transplants) | last = Renal Association | first = | author-link = | date = 2020-03-17 | website = renal.org|archive-url=|archive-date=|url-status= | access-date = 2020-03-23}}</ref>
* '''[[Ampligen]]''' - Ampligen or ''rintatolimod'' is sometimes used by ME/CFS patients, it is an [[antiviral]] immunostimulant rather than immunosuppressing drug, and is being tested for the treatment of COVID-19 illness in Japan.<ref>{{Cite web | url = https://adisinsight.springer.com/drugs/800001203 | title = Rintatolimod - AIM ImmunoTech - AdisInsight|website=adisinsight.springer.com | access-date = 2020-03-23}}</ref> There is no information about whether it may help prevent COVID-19 in ME/CFS patients.
* '''[[Ampligen]]''' - Ampligen or ''rintatolimod'' is sometimes used by ME/CFS patients, it is an [[antiviral]] immunostimulant rather than immunosuppressing drug, and is being tested for the treatment of COVID-19 illness in Japan.<ref>{{Cite web | url = https://adisinsight.springer.com/drugs/800001203 | title = Rintatolimod - AIM ImmunoTech - AdisInsight | website = adisinsight.springer.com | access-date = 2020-03-23}}</ref> There is no information about whether it may help prevent COVID-19 in ME/CFS patients.
*'''[[Fludrocortisone]]''', a [[corticosteroid]] (steroid) - brand names include Florinef. This may be used by patients with [[Postural orthostatic tachycardia syndrome|POTS]], which is common in ME/CFS patients.<ref name="Fludrocortisone-Drugbank">https://www.drugbank.ca/drugs/DB00687</ref>
*'''[[Fludrocortisone]]''', a [[corticosteroid]] (steroid) - brand names include Florinef. This may be used by patients with [[Postural orthostatic tachycardia syndrome|POTS]], which is common in ME/CFS patients.<ref name="Fludrocortisone-Drugbank">https://www.drugbank.ca/drugs/DB00687</ref>
* Other '''[[corticosteroid]]s''' (steroids) if they could suppress the immune system.<ref name="UKgov-vulnerable">{{Cite web | url = https://www.gov.uk/government/publications/covid-19-guidance-on-social-distancing-and-for-vulnerable-people/guidance-on-social-distancing-for-everyone-in-the-uk-and-protecting-older-people-and-vulnerable-adults|website=gov.uk | access-date = 2020-04-06 | title = COVID-19 guidance on social distancing and for vulnerable people | last = Public Health England}}</ref>  
* Other '''[[corticosteroid]]s''' (steroids) if they could suppress the immune system.<ref name="UKgov-vulnerable">{{Cite web | url = https://www.gov.uk/government/publications/covid-19-guidance-on-social-distancing-and-for-vulnerable-people/guidance-on-social-distancing-for-everyone-in-the-uk-and-protecting-older-people-and-vulnerable-adults | website = gov.uk | access-date = 2020-04-06 | title = COVID-19 guidance on social distancing and for vulnerable people | last = Public Health England}}</ref>  
* Any other '''immunosuppressant drugs or therapies''', including chemotherapy treatments and certain targeted cancer treatments<ref name="UKgov-vulnerable" /><ref name="UKgov-extremelyvulnerable">{{Cite web | title = Guidance on shielding and protecting extremely vulnerable people from COVID-19 | url = https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19 | website = gov.uk | access-date = 2020-04-06 | last = Public Health England}}</ref>
* Any other '''immunosuppressant drugs or therapies''', including chemotherapy treatments and certain targeted cancer treatments<ref name="UKgov-vulnerable" /><ref name="UKgov-extremelyvulnerable">{{Cite web | title = Guidance on shielding and protecting extremely vulnerable people from COVID-19 | url = https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19 | website = gov.uk | access-date = 2020-04-06 | last = Public Health England}}</ref>
  {{Quote box|I have now reached the conclusion that people with pre-existing health conditions that make them more vulnerable to lung complications (which may or may not be the case with ME/CFS – at this stage we just don’t know), or have a condition like ME/CFS where an infection such as this will almost certainly cause a relapse, or significant exacerbation of symptoms, need to be doing far more to protect themselves, and to socially distance themselves from other people, than official NHS guidance indicates.
  {{Quote box|I have now reached the conclusion that people with pre-existing health conditions that make them more vulnerable to lung complications (which may or may not be the case with ME/CFS – at this stage we just don’t know), or have a condition like ME/CFS where an infection such as this will almost certainly cause a relapse, or significant exacerbation of symptoms, need to be doing far more to protect themselves, and to socially distance themselves from other people, than official NHS guidance indicates.


In particular, for those who are not housebound, this applies to social mobility and what you can do (and cannot do) if you decide to leave your home.<ref name="MEA16Mar20"/>|author=[[Charles Shepherd]], ME Association | date = Mar 16, 2020 | title = Advice from the UK's ME Association}}
In particular, for those who are not housebound, this applies to social mobility and what you can do (and cannot do) if you decide to leave your home.<ref name="MEA16Mar20"/> | author = [[Charles Shepherd]], ME Association | date = Mar 16, 2020 | title = Advice from the UK's ME Association}}


====<span id="deathrisk">Risk of death or serious complications in ME/CFS patients</span>====
====<span id="deathrisk">Risk of death or serious complications in ME/CFS patients</span>====
Line 98: Line 98:
The biggest worry therefore for ME sufferers is that catching the virus will make their ME much worse, and of course people in the 25% group do not have much leeway.  
The biggest worry therefore for ME sufferers is that catching the virus will make their ME much worse, and of course people in the 25% group do not have much leeway.  


It might even be that worsening of their already severe ME could be a bigger threat to life than the virus itself.<ref name="SpeightMar20" />|author=[[Nigel Speight]] | date = Mar 2020 | title = 25% ME Group for Severe ME}}
It might even be that worsening of their already severe ME could be a bigger threat to life than the virus itself.<ref name="SpeightMar20" /> | author = [[Nigel Speight]] | date = Mar 2020 | title = 25% ME Group for Severe ME}}


====<span id="triggerforME">Risk of developing ME/CFS after COVID-19</span>====
====<span id="triggerforME">Risk of developing ME/CFS after COVID-19</span>====
Line 105: Line 105:


===<span id="medicaladvisors">ME/CFS charity medical advisors' COVID-19 statements</span>===
===<span id="medicaladvisors">ME/CFS charity medical advisors' COVID-19 statements</span>===
*Mar 30, 2020, ME Association, [https://www.meassociation.org.uk/2020/03/me-association-full-guidance-coronavirus-and-me-cfs-by-dr-charles-shepherd-30-march-2020/ ME Association full guidance: Coronavirus and ME/CFS by Dr Charles Shepherd]<ref name="MEA30Mar20">{{Cite web | url = https://www.meassociation.org.uk/2020/03/me-association-full-guidance-coronavirus-and-me-cfs-by-dr-charles-shepherd-30-march-2020/ | title = ME Association full guidance: Coronavirus and ME/CFS by Dr Charles Shepherd {{!}} 30 March 2020 | last = Shepherd | first = Charles | authorlink = Charles Shepherd | date = 2020-04-06 | website = ME Association|language=en-GB|archive-url=|archive-date=|url-status= | access-date = 2020-03-30}}</ref>
*Mar 30, 2020, ME Association, [https://www.meassociation.org.uk/2020/03/me-association-full-guidance-coronavirus-and-me-cfs-by-dr-charles-shepherd-30-march-2020/ ME Association full guidance: Coronavirus and ME/CFS by Dr Charles Shepherd]<ref name="MEA30Mar20">{{Cite web | url = https://www.meassociation.org.uk/2020/03/me-association-full-guidance-coronavirus-and-me-cfs-by-dr-charles-shepherd-30-march-2020/ | title = ME Association full guidance: Coronavirus and ME/CFS by Dr Charles Shepherd {{!}} 30 March 2020 | last = Shepherd | first = Charles | author-link = Charles Shepherd | date = 2020-04-06 | website = ME Association|language=en-GB|archive-url=|archive-date=|url-status= | access-date = 2020-03-30}}</ref>
*Mar 23 2020, Bateman Horne Center, [http://www.batemanhornecenter.org/covid19 COVID-19 resources]
*Mar 23 2020, Bateman Horne Center, [http://www.batemanhornecenter.org/covid19 COVID-19 resources]
*Mar 17, 2020, ME Association, [https://www.meassociation.org.uk/2020/03/coronavirus-covid-19-latest-government-advice-and-what-it-means-for-people-with-me-cfs-17-march-2020/ Coronavirus Covid-19: Latest Government advice and what it means for people with ME/CFS]<ref name="MEA17Mar20">{{Cite web | url = https://www.meassociation.org.uk/2020/03/coronavirus-covid-19-latest-government-advice-and-what-it-means-for-people-with-me-cfs-17-march-2020/ | title = Coronavirus Covid-19: Latest Government advice and what it means for people with ME/CFS {{!}} 17 March 2020 | last = Shepherd | first = Charles | authorlink = Charles Shepherd | date = 2020-03-17 | website = ME Association|language=en-GB|archive-url=|archive-date=|url-status= | access-date = 2020-03-23}}</ref>
*Mar 17, 2020, ME Association, [https://www.meassociation.org.uk/2020/03/coronavirus-covid-19-latest-government-advice-and-what-it-means-for-people-with-me-cfs-17-march-2020/ Coronavirus Covid-19: Latest Government advice and what it means for people with ME/CFS]<ref name="MEA17Mar20">{{Cite web | url = https://www.meassociation.org.uk/2020/03/coronavirus-covid-19-latest-government-advice-and-what-it-means-for-people-with-me-cfs-17-march-2020/ | title = Coronavirus Covid-19: Latest Government advice and what it means for people with ME/CFS {{!}} 17 March 2020 | last = Shepherd | first = Charles | author-link = Charles Shepherd | date = 2020-03-17 | website = ME Association|language=en-GB|archive-url=|archive-date=|url-status= | access-date = 2020-03-23}}</ref>
*Mar 16, 2020, ME Association, [https://www.meassociation.org.uk/2020/03/me-association-guidance-coronavirus-covid-19-and-me-cfs-by-dr-charles-shepherd-16-march-2020/ ME Association Guidance: Coronavirus and ME/CFS by Dr Charles Shepherd]<ref name="MEA16Mar20">{{Cite web | url = https://www.meassociation.org.uk/2020/03/me-association-guidance-coronavirus-covid-19-and-me-cfs-by-dr-charles-shepherd-16-march-2020/ | title = ME Association Guidance: Coronavirus and ME/CFS by Dr Charles Shepherd {{!}} 16 March 2020 | last = Shepherd | first = Charles | authorlink = Charles Shepherd | date = 2020-03-16 | website = ME Association|language=en-GB|archive-url=|archive-date=|url-status= | access-date = 2020-03-23}}</ref>
*Mar 16, 2020, ME Association, [https://www.meassociation.org.uk/2020/03/me-association-guidance-coronavirus-covid-19-and-me-cfs-by-dr-charles-shepherd-16-march-2020/ ME Association Guidance: Coronavirus and ME/CFS by Dr Charles Shepherd]<ref name="MEA16Mar20">{{Cite web | url = https://www.meassociation.org.uk/2020/03/me-association-guidance-coronavirus-covid-19-and-me-cfs-by-dr-charles-shepherd-16-march-2020/ | title = ME Association Guidance: Coronavirus and ME/CFS by Dr Charles Shepherd {{!}} 16 March 2020 | last = Shepherd | first = Charles | author-link = Charles Shepherd | date = 2020-03-16 | website = ME Association|language=en-GB|archive-url=|archive-date=|url-status= | access-date = 2020-03-23}}</ref>
*Mar 2020, 25% ME Group, [https://25megroup.org/download/1796/?v=3236 re Coronavirus and members of the 25% ME Group, Severe ME charity | Message from Dr Willy Weir and Dr Nigel Speight, Medical Advisor to 25% ME Group | Update to the advice given on 29 February 2020],<ref name="SpeightWeirMar20">{{Cite web | url = https://25megroup.org/download/1796/?v=3236 | authorlink = Nigel Speight | last = Speight | first = Nigel | last2 = Weir | first2 = William | authorlink2 = William Weir | title = re Coronavirus and members of the 25% ME Group, Severe ME charity {{!}} Message from Dr Willy Weir and Dr Nigel Speight, Medical Advisor to 25% ME Group {{!}} Update to the advice given on 29 February 2020 | date = Mar 2020 | website = 25megroup.org}}</ref>
*Mar 2020, 25% ME Group, [https://25megroup.org/download/1796/?v=3236 re Coronavirus and members of the 25% ME Group, Severe ME charity | Message from Dr Willy Weir and Dr Nigel Speight, Medical Advisor to 25% ME Group | Update to the advice given on 29 February 2020],<ref name="SpeightWeirMar20">{{Cite web | url = https://25megroup.org/download/1796/?v=3236 | author-link = Nigel Speight | last = Speight | first = Nigel | last2 = Weir | first2 = William | author-link2 = William Weir | title = re Coronavirus and members of the 25% ME Group, Severe ME charity {{!}} Message from Dr Willy Weir and Dr Nigel Speight, Medical Advisor to 25% ME Group {{!}} Update to the advice given on 29 February 2020 | date = Mar 2020 | website = 25megroup.org}}</ref>
*Mar 2020, 25% ME Group, [https://25megroup.org/download/1796/?v=3226 re Coronavirus and members of the 25% ME Group, Severe ME charity Types | Message from Dr Nigel Speight, Medical Advisor to 25% ME Group]<ref name="SpeightMar20">{{Cite web | url = https://25megroup.org/download/1796/?v=3226 | authorlink = Nigel Speight | last = Speight | first = Nigel | title = re Coronavirus and members of the 25% ME Group, Severe ME charity Types {{!}} Message from Dr Nigel Speight, Medical Advisor to 25% ME Group | date = Mar 2020 | website = 25megroup.org|others=[[William Weir]]}}</ref>
*Mar 2020, 25% ME Group, [https://25megroup.org/download/1796/?v=3226 re Coronavirus and members of the 25% ME Group, Severe ME charity Types | Message from Dr Nigel Speight, Medical Advisor to 25% ME Group]<ref name="SpeightMar20">{{Cite web | url = https://25megroup.org/download/1796/?v=3226 | author-link = Nigel Speight | last = Speight | first = Nigel | title = re Coronavirus and members of the 25% ME Group, Severe ME charity Types {{!}} Message from Dr Nigel Speight, Medical Advisor to 25% ME Group | date = Mar 2020 | website = 25megroup.org|others=[[William Weir]]}}</ref>


===Research on ME/CFS and COVID-19===
===Research on ME/CFS and COVID-19===
Line 120: Line 120:
[[File:CDC-Coronavirus-badge-300.png|thumb|upright=1|left|Image author: CDC|alt=image of Coronavirus Disease 2019 (COVID-19)|link=https://www.cdc.gov/coronavirus/2019-ncov/index.html]]
[[File:CDC-Coronavirus-badge-300.png|thumb|upright=1|left|Image author: CDC|alt=image of Coronavirus Disease 2019 (COVID-19)|link=https://www.cdc.gov/coronavirus/2019-ncov/index.html]]
<br style="clear:both;line-height:0">
<br style="clear:both;line-height:0">
The SARS-CoV-2 coronavirus is an ''enveloped virus'', which means it is easier to kill outside the body than ''non-enveloped'' viruses like [[Coxsackievirus]], or [[Poliovirus]].<ref>{{Cite web | url = https://www.epa.gov/pesticides/coronavirus-cases-trigger-epa-rapid-response | title = Coronavirus Cases Trigger EPA Rapid Response | last = US Environmental Protection Agency | first = | authorlink = | date = 2020-01-29 | website = US EPA|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-23}}</ref><ref>{{Cite journal | last = Firquet | first = Swan | authorlink = | last2 = Beaujard | first2 = Sophie | authorlink2 = | last3 = Lobert | first3 = Pierre-Emmanuel | authorlink3 = | last4 = Sané| first4 = Famara | authorlink4 = | last5 = Caloone | first5 = Delphine | authorlink5 = | last6 = Izard | first6 = Daniel | authorlink6 = | last7 = Hober | first7 = Didier | date = June 2015 | title = Survival of Enveloped and Non-Enveloped Viruses on Inanimate Surfaces |url =https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462923/|journal=Microbes and Environments|volume=30|issue=2 | pages = 140–144|doi=10.1264/jsme2.ME14145|issn=1342-6311|pmc=4462923|pmid=25843687|access-date=|quote=|via=}}</ref>
The SARS-CoV-2 coronavirus is an ''enveloped virus'', which means it is easier to kill outside the body than ''non-enveloped'' viruses like [[Coxsackievirus]], or [[Poliovirus]].<ref>{{Cite web | url = https://www.epa.gov/pesticides/coronavirus-cases-trigger-epa-rapid-response | title = Coronavirus Cases Trigger EPA Rapid Response | last = US Environmental Protection Agency | first = | author-link = | date = 2020-01-29 | website = US EPA|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-23}}</ref><ref>{{Cite journal | last = Firquet | first = Swan | author-link = | last2 = Beaujard | first2 = Sophie | author-link2 = | last3 = Lobert | first3 = Pierre-Emmanuel | author-link3 = | last4 = Sané| first4 = Famara | author-link4 = | last5 = Caloone | first5 = Delphine | author-link5 = | last6 = Izard | first6 = Daniel | author-link6 = | last7 = Hober | first7 = Didier | date = June 2015 | title = Survival of Enveloped and Non-Enveloped Viruses on Inanimate Surfaces |url =https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462923/ | journal = Microbes and Environments | volume = 30 | issue = 2 | pages = 140–144|doi=10.1264/jsme2.ME14145|issn=1342-6311|pmc=4462923|pmid=25843687|access-date=|quote=|via=}}</ref>
*[https://www.cdc.gov/coronavirus/2019-ncov/prepare/get-your-household-ready-for-COVID-19.html Get your Household Ready for COVID-19] - CDC
*[https://www.cdc.gov/coronavirus/2019-ncov/prepare/get-your-household-ready-for-COVID-19.html Get your Household Ready for COVID-19] - CDC
*[https://www.americanchemistry.com/Novel-Coronavirus-Fighting-Products-List.pdf Novel Coronavirus (COVID 19)-Fighting Products] - Center for Biocide Chemistries
*[https://www.americanchemistry.com/Novel-Coronavirus-Fighting-Products-List.pdf Novel Coronavirus (COVID 19)-Fighting Products] - Center for Biocide Chemistries
Line 152: Line 152:
*faucets
*faucets
*sinks
*sinks
*hard-backed chairs<ref name="CDC-prevention" /><ref name="CDC-suspectedcases">{{Cite web | url = https://www.cdc.gov/coronavirus/2019-ncov/prepare/cleaning-disinfection.html | title = Coronavirus Disease 2019 (COVID-19) - Environmental Cleaning and Disinfection Recommendations | last = CDC| first = | authorlink = Centers for Disease Control and Prevention | date = 2020-02-11 | website = Centers for Disease Control and Prevention|language=en-us|archive-url=|archive-date=|url-status= | access-date = 2020-03-18}}</ref>
*hard-backed chairs<ref name="CDC-prevention" /><ref name="CDC-suspectedcases">{{Cite web | url = https://www.cdc.gov/coronavirus/2019-ncov/prepare/cleaning-disinfection.html | title = Coronavirus Disease 2019 (COVID-19) - Environmental Cleaning and Disinfection Recommendations | last = CDC| first = | author-link = Centers for Disease Control and Prevention | date = 2020-02-11 | website = Centers for Disease Control and Prevention|language=en-us|archive-url=|archive-date=|url-status= | access-date = 2020-03-18}}</ref>
</div><br style="clear:both; line-height:0" />
</div><br style="clear:both; line-height:0" />
:'''To clean use:'''
:'''To clean use:'''
Line 162: Line 162:
* '''Diluted household bleach''' (mix: 5 tablespoons bleach per gallon of water, OR 4 teaspoons bleach per quart of water), or
* '''Diluted household bleach''' (mix: 5 tablespoons bleach per gallon of water, OR 4 teaspoons bleach per quart of water), or
*'''Alcohol solutions''' with at least 70% alcohol
*'''Alcohol solutions''' with at least 70% alcohol
:Follow manufacturer’s instructions for application and ''proper ventilation''. Check the product is not past its expiration date. ''(Updated Mar 18, 2020)''<ref name="CDC-prevention">{{Cite web | url = https://www.cdc.gov/coronavirus/2019-ncov/prepare/prevention.html | title = Coronavirus Disease 2019 (COVID-19) – Prevention & Treatment | last = CDC| first = | authorlink = Centers for Disease Control and Prevention | date = 2020-03-16 | website = Centers for Disease Control and Prevention|language=en-us|archive-url=|archive-date=|url-status= | access-date = 2020-03-17}}</ref>
:Follow manufacturer’s instructions for application and ''proper ventilation''. Check the product is not past its expiration date. ''(Updated Mar 18, 2020)''<ref name="CDC-prevention">{{Cite web | url = https://www.cdc.gov/coronavirus/2019-ncov/prepare/prevention.html | title = Coronavirus Disease 2019 (COVID-19) – Prevention & Treatment | last = CDC| first = | author-link = Centers for Disease Control and Prevention | date = 2020-03-16 | website = Centers for Disease Control and Prevention|language=en-us|archive-url=|archive-date=|url-status= | access-date = 2020-03-17}}</ref>


:'''Check for updates:'''
:'''Check for updates:'''
Line 179: Line 179:
*cardboard - 24 hours
*cardboard - 24 hours
*stainless steel - 2 to 3 days
*stainless steel - 2 to 3 days
*plastic - 2 to 3 days<ref name="stablesurfacesPRMar20">{{Cite web | url = https://www.nih.gov/news-events/news-releases/new-coronavirus-stable-hours-surfaces | title = New coronavirus stable for hours on surfaces | last = National Institutes of Health | first = | authorlink = National Institutes of Health | date = 2020-03-17 | website = National Institutes of Health (NIH)|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-25}}</ref><ref name="Tellier2006">{{Cite journal | last = Tellier | first = Raymond | authorlink = | date = Nov 2006 | title = Review of Aerosol Transmission of Influenza A Virus |url =https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372341/|journal=Emerging Infectious Diseases|volume=12|issue=11 | pages = 1657–1662|doi=10.3201/eid1211.060426|issn=1080-6040|pmc=3372341|pmid=17283614|access-date=|quote=|via=}}</ref>
*plastic - 2 to 3 days<ref name="stablesurfacesPRMar20">{{Cite web | url = https://www.nih.gov/news-events/news-releases/new-coronavirus-stable-hours-surfaces | title = New coronavirus stable for hours on surfaces | last = National Institutes of Health | first = | author-link = National Institutes of Health | date = 2020-03-17 | website = National Institutes of Health (NIH)|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-25}}</ref><ref name="Tellier2006">{{Cite journal | last = Tellier | first = Raymond | author-link = | date = Nov 2006 | title = Review of Aerosol Transmission of Influenza A Virus |url =https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372341/ | journal = Emerging Infectious Diseases | volume = 12 | issue = 11 | pages = 1657–1662|doi=10.3201/eid1211.060426|issn=1080-6040|pmc=3372341|pmid=17283614|access-date=|quote=|via=}}</ref>


This means direct contact with an infected person is not needed to contact the illness.<ref name="stablesurfacesPRMar20" /> Surgical [[#facemasks|face masks]] have not been effective against aerosols in previous influenza outbreaks like swine flu, but N95 respirators have been effective.<ref name="Tellier2006" />
This means direct contact with an infected person is not needed to contact the illness.<ref name="stablesurfacesPRMar20" /> Surgical [[#facemasks|face masks]] have not been effective against aerosols in previous influenza outbreaks like swine flu, but N95 respirators have been effective.<ref name="Tellier2006" />
Line 196: Line 196:
*soiled items and surfaces (as needed)
*soiled items and surfaces (as needed)
*if a separate bathroom is not available, the bathroom should be cleaned and disinfected after each use by an ill person
*if a separate bathroom is not available, the bathroom should be cleaned and disinfected after each use by an ill person
*provide personal cleaning and disinfectant supplies in ill person's room (unless unsafe, e.g. they are a young child) - include tissues, paper towels, cleaners and EPA-registered disinfectants<ref name="CDC-prevention" /><ref name="CDC-suspectedcases" /><ref name="CDCDisinfectYourHome">{{Cite web | url = https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/disinfecting-your-home.html | title = Disinfecting your home {{!}} Coronavirus Disease 2019 (COVID-19) | last = CDC| first = | authorlink = | date = 2020-02-11 | website = Centers for Disease Control and Prevention|language=en-us|archive-url=|archive-date=|url-status= | access-date = 2020-10-06}}</ref></div>
*provide personal cleaning and disinfectant supplies in ill person's room (unless unsafe, e.g. they are a young child) - include tissues, paper towels, cleaners and EPA-registered disinfectants<ref name="CDC-prevention" /><ref name="CDC-suspectedcases" /><ref name="CDCDisinfectYourHome">{{Cite web | url = https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/disinfecting-your-home.html | title = Disinfecting your home {{!}} Coronavirus Disease 2019 (COVID-19) | last = CDC| first = | author-link = | date = 2020-02-11 | website = Centers for Disease Control and Prevention|language=en-us|archive-url=|archive-date=|url-status= | access-date = 2020-10-06}}</ref></div>


<div role="note" class="hatnote navigation-searchable" style="padding:0">Take additional steps covering '''soft surfaces, food, laundry, and trash''' as described{{colon}}
<div role="note" class="hatnote navigation-searchable" style="padding:0">Take additional steps covering '''soft surfaces, food, laundry, and trash''' as described{{colon}}
Line 202: Line 202:


==<span id="sari">COVID-19 pneumonia</span>==
==<span id="sari">COVID-19 pneumonia</span>==
'''Severe Acute Respiratory Infection''' (SARI) is a type of pneumonia caused by COVID-19 which develops in severely ill COVID-19 patients.<ref name="vitCtrial">{{Cite web | url = https://clinicaltrials.gov/ct2/show/NCT04264533 | title = Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia - ClinicalTrials.gov|website=clinicaltrials.gov|language=en | access-date = 2020-03-22}}</ref> A clinical trial is in progress to determine if intravenous [[vitamin C]] is an effective treatment for SARI.<ref name="vitCtrial" />
'''Severe Acute Respiratory Infection''' (SARI) is a type of pneumonia caused by COVID-19 which develops in severely ill COVID-19 patients.<ref name="vitCtrial">{{Cite web | url = https://clinicaltrials.gov/ct2/show/NCT04264533 | title = Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia - ClinicalTrials.gov | website = clinicaltrials.gov|language=en | access-date = 2020-03-22}}</ref> A clinical trial is in progress to determine if intravenous [[vitamin C]] is an effective treatment for SARI.<ref name="vitCtrial" />


==<span id="ards">Acute Respiratory Distress Syndrome</span>==
==<span id="ards">Acute Respiratory Distress Syndrome</span>==
ARDS is another complication of severe COVID-19, and may develop after 5-8 days of illness, along with pneumonitis and shortness of breath.<ref name="Jiang2020">{{Cite journal | url = http://techscience.com/cmc/v63n1/38464 | title = Towards an Artificial Intelligence Framework for Data-Driven  Prediction of Coronavirus Clinical Severity | last = Jiang | first = X | authorlink = | last2 = Coffee | first2 = M | authorlink2 = | date = 2020 | website = | pages = 537-551|archive-url=|archive-date=|url-status= | access-date = 2020-04-01 | last3 = Bari | first3 = A | last4 = Wang | first4 = J | last5 = Jiang | first5 = X | last6 = Huang | first6 = J | last7 = Shi | first7 = J | last8 = Dai | first8 = J | last9 = Cai | first9 = J | last10 = Zhang | first10 = T | last11 = Wu| first11 = Z | last12 = He | first12 = G | last13 = Huang | last14 = Y|volume=63|issue=1|journal=CMC-Computers, Materials & Continua}}</ref> ARDS is a life-threatening condition that involves the patient's lungs becoming inflamed, and being unable to produce enough oxygen for the body's vital organs.<ref name="ARDS-NHS">{{Cite web | url = https://www.nhs.uk/conditions/acute-respiratory-distress-syndrome/ | title = Acute respiratory distress syndrome (ARDS) | last = National Health Service | first = | authorlink = National Health Service | date = 2017-10-17 | website = nhs.uk|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-04-01}}</ref>
ARDS is another complication of severe COVID-19, and may develop after 5-8 days of illness, along with pneumonitis and shortness of breath.<ref name="Jiang2020">{{Cite journal | url = http://techscience.com/cmc/v63n1/38464 | title = Towards an Artificial Intelligence Framework for Data-Driven  Prediction of Coronavirus Clinical Severity | last = Jiang | first = X | author-link = | last2 = Coffee | first2 = M | author-link2 = | date = 2020 | website = | pages = 537-551|archive-url=|archive-date=|url-status= | access-date = 2020-04-01 | last3 = Bari | first3 = A | last4 = Wang | first4 = J | last5 = Jiang | first5 = X | last6 = Huang | first6 = J | last7 = Shi | first7 = J | last8 = Dai | first8 = J | last9 = Cai | first9 = J | last10 = Zhang | first10 = T | last11 = Wu | first11 = Z | last12 = He | first12 = G | last13 = Huang | last14 = Y | volume = 63 | issue = 1 | journal = CMC-Computers, Materials & Continua}}</ref> ARDS is a life-threatening condition that involves the patient's lungs becoming inflamed, and being unable to produce enough oxygen for the body's vital organs.<ref name="ARDS-NHS">{{Cite web | url = https://www.nhs.uk/conditions/acute-respiratory-distress-syndrome/ | title = Acute respiratory distress syndrome (ARDS) | last = National Health Service | first = | author-link = National Health Service | date = 2017-10-17 | website = nhs.uk|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-04-01}}</ref>


== Long COVID ==
== Long COVID ==
Line 211: Line 211:


==Myth, Hoaxes, Scams and Fake News==
==Myth, Hoaxes, Scams and Fake News==
Many myths, hoaxes and fake news have been spreading, particularly on social media, some of which claim to be from doctors or health professionals.<ref name="WHOmyths">{{Cite web | url = https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters | title = Coronavirus 2019 {{!}} Myth busters | last = World Health Organization | first = | authorlink = World Health Organization | date = |website=[[World Health Organization]]|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-17}}</ref><ref name="BuzzfeedHoax3Mar20">{{Cite web | url = https://www.buzzfeednews.com/article/janelytvynenko/coronavirus-disinformation-spread | title = Here Are Some Of The Coronavirus Hoaxes That Spread In The First Few Weeks|website=BuzzFeed News|language=en | access-date = 2020-03-17}}</ref> Scam include seeking fake cures or ineffective protective equipment like masks, scammers pretending to be from the World Health Organization asking for donations, or a stranger asking for money on behalf of a relative's medical bills.<ref name="FTC-scams">{{Cite web | url = https://www.consumer.ftc.gov/features/coronavirus-scams-what-ftc-doing | title = Coronavirus Scams: What the FTC is doing | last = FTC| first = | authorlink = | date = 2020-03-06 | website = Consumer Information|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-17}}</ref><ref name="WHO-cybersecurity">{{Cite web | url = https://www.who.int/about/communications/cyber-security | title = Communications {{!}} Cybersecurity | last = World Health Organization | first = | authorlink = World Health Organization | date = |website=[[World Health Organization]]|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-17}}</ref>
Many myths, hoaxes and fake news have been spreading, particularly on social media, some of which claim to be from doctors or health professionals.<ref name="WHOmyths">{{Cite web | url = https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters | title = Coronavirus 2019 {{!}} Myth busters | last = World Health Organization | first = | author-link = World Health Organization | date = | website = [[World Health Organization]]|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-17}}</ref><ref name="BuzzfeedHoax3Mar20">{{Cite web | url = https://www.buzzfeednews.com/article/janelytvynenko/coronavirus-disinformation-spread | title = Here Are Some Of The Coronavirus Hoaxes That Spread In The First Few Weeks | website = BuzzFeed News|language=en | access-date = 2020-03-17}}</ref> Scam include seeking fake cures or ineffective protective equipment like masks, scammers pretending to be from the World Health Organization asking for donations, or a stranger asking for money on behalf of a relative's medical bills.<ref name="FTC-scams">{{Cite web | url = https://www.consumer.ftc.gov/features/coronavirus-scams-what-ftc-doing | title = Coronavirus Scams: What the FTC is doing | last = FTC| first = | author-link = | date = 2020-03-06 | website = Consumer Information|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-17}}</ref><ref name="WHO-cybersecurity">{{Cite web | url = https://www.who.int/about/communications/cyber-security | title = Communications {{!}} Cybersecurity | last = World Health Organization | first = | author-link = World Health Organization | date = | website = [[World Health Organization]]|language=en|archive-url=|archive-date=|url-status= | access-date = 2020-03-17}}</ref>


*[https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters Coronavirus disease (COVID-19) advice for the public: Myth busters] - World Health Organization
*[https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters Coronavirus disease (COVID-19) advice for the public: Myth busters] - World Health Organization

Latest revision as of 22:22, May 18, 2023

COVID-19, commonly referred to as COVID or even corona, is Coronavirus Disease 19, an infectious respiratory illness caused by the novel (new) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus discovered in 2019.[1][2][3][4]

Computer-aided identification of lesions on the lungs of COVID-19 patients.
COVID-19 can cause lesions on lungs, and pneumonia.
Author: Shen et al. 2020. Journal of Pharmaceutical Analysis. Copyright: CC-BY-NC-ND-4.0

COVID-19 was first identified in Wuhan, China, in December 2019,[1] and can infect babies, children, and adults of any age.[5] It spread globally, resulting in the 2019-2020 coronavirus pandemic.[6][7] There is some evidence that COVID-19 may be a disease of the blood vessels, as well as a respiratory disease.[8][9]

Symptoms[edit | edit source]

Symptoms are usually mild and begin gradually, although around 1 in 6 people with COVID-19 need medical help.[1] Some people become infected but don't develop any symptoms and don't feel unwell.[10] These symptoms may appear 1-14 days after exposure; most commonly around five days.[10][11]

Mild COVID-19[edit | edit source]

The phrases mild symptoms and mild or moderate cases have commonly been used to decribe any patients not in need of urgent hospitalisation during the pandemic,[12][13] yet considerable numbers of patients with COVID-19 who were considered mild or moderate cases were extremely ill or developed long-term symptoms which prevented any return to work or normal life.[14][15][16]

Common Symptoms[edit | edit source]

Most patients only have one or two of the common symptoms.[10][18][19][20]

Other Symptoms[edit | edit source]

The World Health Organization that people call their doctor if they experience fever, cough or difficulty breathing.

Emergency Warning Signs*[edit | edit source]

*This list is not all inclusive. Consult your medical provider for any other symptoms that are severe or concerning.[11]

Additionally, there are reports that patients have lost or have a reduced sense of smell, or lost or distorted of taste, but are otherwise asymptomatic.[21]

The American Academy of Otolaryngology on Sunday posted information on its website[22] saying that mounting anecdotal evidence indicates that lost or reduced sense of smell and loss of sense of taste are significant symptoms associated with Covid-19, and that they have been seen in patients who ultimately tested positive with no other symptoms.[21]

The symptoms, in the absence of allergies or sinusitis, should alert doctors to screen patients for the virus and “warrant serious consideration for self isolation and testing of these individuals,” the academy said.[21]

Neurological symptoms[edit | edit source]

Mao et al. (2020) reported that 36% of a group of 214 COVID-19 patients admitted to hospitals in Wuhan, China, had "neurologic manifestations" of the disease.[23]

Neurological symptoms were:

Asymptomatic carriers[edit | edit source]

The SARS-CoV-2 virus causes COVID-19.
Author: CDC

A number of studies have found that some people who test positive for COVID-19 do not have any symptoms of illness or a raised temperature, and have normal blood test results, but are able to infect others, some of whom developed severe COVID-19 pneumonia as a result of COVID-19.[24][25][26] Some asymptomatic carriers have abnormal chest CT scans, and some do not. False negative tests have also been reported.[24][25]

Estimates of the number of asymptomatic carriers vary wildly. Mizumoto et al. (2020) estimated that asymptomatic carriers accounted for 17.9% of the COVID-19 positive people on the Diamond Princess cruise ship, which was quarantined for 14 day after a previous passenger developed the illness.[18]

Recovered patients testing positive[edit | edit source]

Lan et al (2020) identified a group of 4 recovered patients who continued to test positive for COVID-19 after recovery; suggesting that they may still be infectious.[19] It is not known whether patients who have recovered may be reinfected later, or whether those who later needed treatment actually relapsed, or if recovered patients who later test positive do so because of issues with the diagnostic test's accuracy.[27] Another study found group of 5 recovered patients were found to have reactivated COVID-19.[28]

ME/CFS[edit | edit source]

EmbedVideo received a list of URL arguments that contained malformed data or blank arguments.


Risk of COVID-19 in patients with ME/CFS[edit | edit source]

There is a lack of evidence about ME/CFS patients developing COVID-19 illness; but a number of medical advisors have given their expert opinions on this. Immunologist and ME researcher Dr Nancy Klimas has said she believes people with ME/CFS are at a little higher risk of developing COVID-19 after exposure to the virus;[29] Dr Nigel Speight, Dr William Weir and Dr Charles Shepherd have said they do not think there is an increased risk.[30][31][32] Dr Lucinda Bateman has said this is unknown.[33]Klimas, Speight, Weir, Shepherd and Bateman have all advised ME/CFS patients to take additional precautions, and highlighted that there is a risk of ME/CFS becoming significantly worse after viral infections or after COVID-19.[29][30][31][32][33]

ME/CFS includes immune symptoms including a sore throat, swollen lymph nodes, and flu-like symptoms, but patients are generally not considered to be severely immunocompromised, and immunosuppressant medications are unlikely to be used by most ME/CFS patients. [29] [34][35] A study in 2013 assessed immune system responses to the flu vaccine in people with ME/CFS, and found them similar to the immune responses of healthy controls, which indicated that vaccine effectiveness was similar in ME/CFS patients, although the study did not include a long-term follow-up to assess duration of vaccine effectiveness or overall effect on ME/CFS symptoms.[36] This means most ME/CFS patients would not be considered to be at very high risk of COVID-19 illness.[29]

The unproven autoimmune hypothesis states that a subtype of ME involves autoimmunity, which is an overactive immune system rather than a weakened immune response.[37] Evidence for this theory is limited.

Drug related risks[edit | edit source]

The following drugs may be used for some ME/CFS symptoms and are a possible concern

  • Ibuprofen - Ibuprofen drugs (Nurofen, Bruprofen, Advil, Midol, Motrin, Motrin) are anti-inflammatories commonly used for cold/flu symptoms and for ME/CFS. There have been some reports that ibuprofen taken for COVID-19 may prolong the illness and increase it's severity. Several countries including the UK and France now recommend that people with suspected or confirmed COVID-19 avoid ibuprofen and use paracetamol / acetaminophen (e.g., Tylenol) instead, although the evidence for this is relatively limited.[32][38][39] There is no suggestion that ibuprofen affects the risk of catching COVID-19.
  • Rituximab - The MS Society has stated that taking rituximab, which has been used in clinical trials for ME/CFS, may affect the risk of catching COVID-19.[40][41]
  • Ampligen - Ampligen or rintatolimod is sometimes used by ME/CFS patients, it is an antiviral immunostimulant rather than immunosuppressing drug, and is being tested for the treatment of COVID-19 illness in Japan.[42] There is no information about whether it may help prevent COVID-19 in ME/CFS patients.
  • Fludrocortisone, a corticosteroid (steroid) - brand names include Florinef. This may be used by patients with POTS, which is common in ME/CFS patients.[43]
  • Other corticosteroids (steroids) if they could suppress the immune system.[44]
  • Any other immunosuppressant drugs or therapies, including chemotherapy treatments and certain targeted cancer treatments[44][45]
Advice from the UK's ME Association

I have now reached the conclusion that people with pre-existing health conditions that make them more vulnerable to lung complications (which may or may not be the case with ME/CFS – at this stage we just don’t know), or have a condition like ME/CFS where an infection such as this will almost certainly cause a relapse, or significant exacerbation of symptoms, need to be doing far more to protect themselves, and to socially distance themselves from other people, than official NHS guidance indicates.

In particular, for those who are not housebound, this applies to social mobility and what you can do (and cannot do) if you decide to leave your home.[32]

Charles Shepherd, ME Association


Risk of death or serious complications in ME/CFS patients[edit | edit source]

25% ME Group for Severe ME

Although ME is a "chronic condition" my gut feeling is that they are not actually at greater risk of dying from the virus itself than healthy people. The conditions which put people at extra risk would be things like severe asthma or COPD, or immunosuppressed people eg those on chemotherapy for cancer.

The biggest worry therefore for ME sufferers is that catching the virus will make their ME much worse, and of course people in the 25% group do not have much leeway.

It might even be that worsening of their already severe ME could be a bigger threat to life than the virus itself.[31]


Risk of developing ME/CFS after COVID-19[edit | edit source]

ME/CFS has been linked to many different viruses, but it is not known what the likelihood is of developing ME/CFS after COVID-19 illness.

ME/CFS charity medical advisors' COVID-19 statements[edit | edit source]

Research on ME/CFS and COVID-19[edit | edit source]

COVID-19 is a new illness and research on the effects on ME/CFS patients has not been published yet. Patient surveys in progress include:

A Dutch patient organization survey to assess if the risk of contracting COVID-19 is higher for those with ME/CFS, and if symptoms are more severe in ME/CFS patients.[48][49] The European ME Alliance is suggesting that non-Dutch speakers use an online translation tool to complete it.[48]

Prevention[edit | edit source]

image of Coronavirus Disease 2019 (COVID-19)
Image author: CDC


The SARS-CoV-2 coronavirus is an enveloped virus, which means it is easier to kill outside the body than non-enveloped viruses like Coxsackievirus, or Poliovirus.[50][51]

CDC advice[edit | edit source]

  • Know How it Spreads
  • Clean your hands often
  • Avoid close contact
  • Stay home if you're sick (may have the virus)
  • Cover coughs and sneezes
  • Wear a face mask if you are sick (may have the virus)
  • Clean and disinfect

High touch surfaces: disinfect daily[edit | edit source]

High-touch surfaces: disinfect daily. Tables, doorknobs, light switches, countertops, handles, desks, phones keyboards, remote controls, toilets, faucets, sinks, hard-backed chairs. Source: Coronavirus disease 19 Prevention - CDC, March 2020. Public domain image.


The CDC currently recommends people clean AND disinfect frequently touched surfaces daily:

  • tables
  • doorknobs
  • light switches
  • countertops
  • handles
  • desks
  • phones
  • keyboards
  • remote controls
  • toilets
  • faucets
  • sinks
  • hard-backed chairs[52][53]


To clean use:
  • Detergent or soap and water prior to disinfection. [52]
To disinfect use:
  • Disinfectants used against SARS-CoV-2 (list)
  • Most common EPA-registered household disinfectants will work, or
  • Diluted household bleach (mix: 5 tablespoons bleach per gallon of water, OR 4 teaspoons bleach per quart of water), or
  • Alcohol solutions with at least 70% alcohol
Follow manufacturer’s instructions for application and proper ventilation. Check the product is not past its expiration date. (Updated Mar 18, 2020)[52]
Check for updates:

Suspected or confirmed COVID-19 cases:
If possible the sick person should also clean:

  • soiled items and surfaces (as needed)
  • if a separate bathroom is not available, the bathroom should be cleaned and disinfected after each use by an ill person
  • provide personal cleaning and disinfectant supplies in ill person's room (unless unsafe, e.g. they are a young child) - include tissues, paper towels, cleaners and EPA-registered disinfectants[52][53]

Coronavirus transmission from surfaces[edit | edit source]

The new coronavirus can survive on different surfaces for hours or days:

  • small, airborne virus particles (aerosols) - 3 hours
  • copper - 4 hours
  • cardboard - 24 hours
  • stainless steel - 2 to 3 days
  • plastic - 2 to 3 days[54][55]

This means direct contact with an infected person is not needed to contact the illness.[54] Surgical face masks have not been effective against aerosols in previous influenza outbreaks like swine flu, but N95 respirators have been effective.[55]

Disinfecting your home if someone is sick[edit | edit source]

The following is an abbreviated bullet-point list from the Centers for Disease Control and Prevention (CDC) article "Everyday Steps and Extra Steps When Someone Is Sick"[56]


Suspected or confirmed COVID-19 cases:


If possible the sick person should also clean:

  • soiled items and surfaces (as needed)
  • if a separate bathroom is not available, the bathroom should be cleaned and disinfected after each use by an ill person
  • provide personal cleaning and disinfectant supplies in ill person's room (unless unsafe, e.g. they are a young child) - include tissues, paper towels, cleaners and EPA-registered disinfectants[52][53][57]